Tech Company Financing Transactions
Sound Pharmaceuticals Funding Round
On 6/7/2018, Sound Pharmaceuticals raised $8.4 million in investment from private investors.
Transaction Overview
Company Name
Announced On
6/7/2018
Transaction Type
Venture Equity
Amount
$8,408,576
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4010 Stone Way N 120
Seattle, WA 98103
USA
Seattle, WA 98103
USA
Phone
Website
Email Address
Overview
Sound Pharmaceuticals (SPI) is a privately held biopharmaceutical company in Seattle, WA. Our goal is to develop prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Kil
Chief Scientific Officer
Eric Lynch
VP - Operations
Paul Hoskins
Browse more venture capital transactions:
Prev: 6/7/2018: Squiggle Park venture capital transaction
Next: 6/7/2018: Qumulo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs